Association between gastrointestinal symptoms and affectivity in patients with bipolar disorder

World Journal of Gastroenterology

Volumn 22, Issue 38, 2016, Pages 8540-8548

  Karling, Pontus ^a   Maripuu, Martin ^a   Wikgren, Mikael ^a   Adolfsson, Rolf ^a   Norrback, Karl Fredrik ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Anxiety; Bipolar disorder; Brain Gut axis; Depression; Dyspepsia; Functional gastrointestinal disorder; Gastrointestinal Symptom Rating Scaleirritable bowel syndrome; Hospital Anxiety and Depression Scale; Irritable bowel syndrome; Stress

Indexed keywords

ABDOMINAL PAIN; ADULT; ANXIETY; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BLOATING; CASE CONTROL STUDY; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE ASSOCIATION; DYSPEPSIA; FEMALE; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL SYMPTOM RATING SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PERCEIVED STRESS SCALE; RETROSPECTIVE STUDY; SATIETY; SEX DIFFERENCE; AGED; COMPLICATION; GASTROINTESTINAL DISEASE; MIDDLE AGED; PRIMARY HEALTH CARE; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANXIETY; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CONSTIPATION; DEPRESSION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES;

EID: 84991101897     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i38.8540     Document Type: Article

References (43)

1. Palsson OS, Whitehead WE. The growing case for hypnosis as adjunctive therapy for functional gastrointestinal disorders. Gastroenterology 2002; 123: 2132-2135 [PMID: 12454867 DOI: 10.1053/gast.2002.32392]
2. Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 2012; 61: 1284-1290 [PMID: 22234979 DOI: 10.1136/ gutjni.2011.300.474]
3. Mayer EA, Craske M, Naliboff BD. Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry 2001; 62. Suppl 8: 28-36; discussion 37 [PMID: 12108819]
4. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol 2001; 96: 1072-1079 [PMID: 11316149 DOI: 10.1111/i1572-0241.2001.03741.x]
5. Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. Am J Ther 2003; 10: 61-67 [PMID: 12522523 DOI: 000453 91-200301000-00014]
6. Karling P, Danielsson A, Adolfsson R, Norrback KF. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission. Neurogastroenterol Motil 2007; 19: 896-904 [PMID: 17973640 DOI: 10.1111/j.1365-2982.2007.00967.x]
7. Corruble E, Guelfi JD. Pain complaints in depressed inpatients. Psychopathology 2000; 33: 307-309 [PMID: 11060514]
8. Gerber PD, Barrett JE, Barrett JA, Oxman TE, Manheimer E, Smith R, Whiting RD. The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med 1992; 7: 170-173 [PMID: 1487765]
9. Cadoret RJ, Widmer RB, North C. Depression in family practice: long-term prognosis and somatic complaints. J Fam Pract 1980; 10: 625-629 [PMID: 7365435]
10. Swanson SA, Crow SJ, Le Grange D, Swendsen J, Merikangas KR. Prevalence and correlates of eating disorders in adolescents. Results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry 2011; 68: 714-723 [PMID: 21383252 DOI: 10.1001/archgenpsychiatry.2011.12]
11. Leboyer M, Kupfer DJ. Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry 2010; 71: 1689-1695 [PMID: 21190640 DOI: 10.4088/JCP.10m06347yel]
12. Bryant-Comstock L, Stender M, Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord 2002; 4: 398-405 [PMID: 12519100 DOI: 10.1034/j.1399-5618.2002.011.48x]
13. Rush AJ, Weissenburger JE. Melancholic symptom features and DSM-IV. Am J Psychiatry 1994; 151: 489-498 [PMID: 8147445 DOI: 10.1176/aip.151.4.489]
14. Herlitz A, Nilsson LG, Bäckman L. Gender differences in episodic memory. Mem Cognit 1997; 25: 801-811 [PMID: 9421566 DOI: 10.3578/BF03211324]
15. Wiklund IK, Fullerton S, Hawkey CJ, Jones RH, Longstreth GF, Mayer EA, Peacock RA, Wilson IK, Naesdal J. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol 2003; 38: 947-954 [PMID: 14531531 DOI: 10.1080/00365520310004209]
16. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681-687 [PMID: 8210982 DOI: 10.3109 /00365529309098272]
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370 [PMID: 6880820 DOI: 10.1111/j.1600-0447.1983.tb09716.x]
18. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results. J Psychosom Res 1997; 42: 17-41 [PMID: 9055211 DOI: 10.1016/S0022-3999(96)00216-4]
19. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77 [PMID: 11832252 DOI: 10.1016/S0022(01)00296-3]
20. Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Luzi C, Andreoli A. Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research. J Psychosom Res 1993; 37: 19-32 [PMID: 8421257 DOI: 10.1016/0022-3999(93)90120-5]
21. Bergdahl J, Bergdahl M. Perceived stress in adults: prevalence and association of depression, anxiety and medication in a Swedish population. Stress and Health 2002; 18: 235-241 [DOI: 10.1002/ smi.946]
22. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491 [PMID: 16678561 DOI: 10.1053/j.gastro.2005.11.061]
23. Naliboff BD, Berman S, Chang L, Derbyshire SW, Suyenobu B, Vogt BA, Mandelkern M, Mayer EA. Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology 2003; 124: 1738-1747 [PMID: 12806606 DOI: 10.1016/ S0016-5085(03)00400-1]
24. Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 2004; 53: 1595-1601 [PMID: 15479679 DOI: 10.1136/gut.2003.028514]
25. Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 2011; 140: 91-100 [PMID: 20696168 DOI: 10.1053/j.gastro.2010.07.053]
26. Larsson MB, Tillisch K, Craig AD, Engström M, Labus J, Naliboff B, Lundberg P, Ström M, Mayer EA, Walter SA. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology 2012; 142: 463-472.e3 [PMID: 22108191 DOI: 10.1053/j.gastro.2011.11.022]
27. Guthrie E, Barlow J, Fernandes L, Ratcliffe J, Read N, Thompson DG, Tomenson B, Creed F. Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome. Psychosom Med 2004; 66: 578-582 [PMID: 15272106 DOI: 10.1097/01. psy.0000128899.22514.c0]
28. Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2014; 109: 1350-1365; quiz 1366 [PMID: 24935275 DOI: 10.1038/ajg.2014.148]
29. Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol 2003; 98: 2209-2218 [PMID: 14572570 DOI: 10.1111/j.1572-0241.2003.07716.x]
30. Keightley PC, Koloski NA, Talley NJ. Pathways in gut-brain communication: evidence for distinct gut-to-brain and brain-togut syndromes. Aust N Z J Psychiatry 2015; 49: 207-214 [PMID: 25710826 DOI: 10.1177/0004867415569801]
31. Claes SJ. Corticotropin-releasing hormone (CRH) in psychiatry: from stress to psychopathology. Ann Med 2004; 36: 50-61 [PMID: 15000347 DOI: 10.1080/07853890310017044]
32. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000; 47: 861-869 [PMID: 11076888 DOI: 10.1136/ gut.47.6.861]
33. Schulkin J, Morgan MA, Rosen JB. A neuroendocrine mechanism for sustaining fear. Trends Neurosci 2005; 28: 629-635 [PMID: 16214230 DOI: 10.1016/j.tins.2005.09.009]
34. Taché Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 2001; 280: G173-G177 [PMID: 11208537]
35. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998; 42: 845-849 [PMID: 9691924 DOI: 10.1136/ gut.42.6.845]
36. Fukudo S, Kanazawa M, Kano M, Sagami Y, Endo Y, Utsumi A, Nomura T, Hongo M. Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome. J Gastroenterol 2002; 37. Suppl 14: 145-150 [PMID: 12572883 DOI: 10.1007/BF03326434]
37. Saito-Nakaya K, Hasegawa R, Nagura Y, Ito H, Fukudo S. Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension. Neurogastroenterol Motil 2008; 20: 1147-1156 [PMID: 18761632 DOI: 10.1111/j.1365-2982.2008.01151. x]
38. Aggarwal A, Cutts TF, Abell TL, Cardoso S, Familoni B, Bremer J, Karas J. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology 1994; 106: 945-950 [PMID: 8143999]
39. Messay B, Lim A, Marsland AL. Current understanding of the bidirectional relationship of major depression with inflammation. Biol Mood Anxiety Disord 2012; 2: 4 [PMID: 22738397 DOI: 10.1186/2045-5380-2-4]
40. Zhou L, Foster JA. Psychobiotics and the gut-brain axis: in the pursuit of happiness. Neuropsychiatr Dis Treat 2015; 11: 715-723 [PMID: 25834446 DOI: 10.2147/NDT.S61997]
41. Karling P, Danielsson Å, Wikgren M, Söderström I, Del-Favero J, Adolfsson R, Norrback KF. The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome. PLoS One 2011; 6: e18035 [PMID: 21437260]
42. Karling P, Norrback KF, Adolfsson R, Danielsson A. Gastrointestinal symptoms are associated with hypothalamicpituitary-adrenal axis suppression in healthy individuals. Scand J Gastroenterol 2007; 42: 1294-1301 [PMID: 17852841 DOI: 10.1080/00365520701395945]
43. Mikocka-Walus AA, Turnbull DA, Andrews JM, Moulding NT, Holtmann GJ. The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008; 28: 475-483 [PMID: 18532989 DOI: 10.1111/j.1365-2036.2008.0375.x]